Stanley S. Scott Cancer Center Invited Speaker Series

(Sponsored CME series)

Target Audience: The target audience for this activity includes oncologists, hematologists, nurses, techs, medical students, and health care providers with an interest in cancer treatment and research.

Objectives: After participating in this educational activity, the attendee should be better able to:

1. Effectively communicate the nature and scope of a wide range of problems potentially facing cancer patients with those at all levels of cancer research and treatment
2. Apply the latest scientific research into daily practice of managing patients with oncologic conditions
3. Collaborate with others in the field of cancer research and treatment in order to maximize available resources for the treatment of cancer patients
4. Institute new diagnostic and treatment strategies to improve overall healthcare for cancer patients

Accreditation/Designation of Credit: LSU School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.

LSU School of Medicine designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

 

LSU School of Medicine presents this activity for educational purposes only and does not endorse any product, content of presentation or exhibit. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected because of their recognized expertise.

 

Facilitated by: The LSU Health Sciences Center – Institute of Professional Education

 

Faculty Disclosure:  It is the policy of Continuing Education at LSU School of Medicine to plan and implement all of its educational activities in accordance with the ACCME's Essential Areas and Policies to ensure balance, independence, objectivity and scientific rigor. In accordance with the ACCME's 2004 Standards for Commercial Support, everyone who is in a position to control the content of an educational activity certified for AMA PRA Category 1 Credit™ is required to disclose all relevant financial relationships with any commercial interests within the past 12 months that creates a real or apparent conflict of interest. Individuals who do not disclose are disqualified from participating in a CME activity. Individuals with potential for influence or control of CME content include planners and planning committee members, authors, teachers, educational activity directors, educational partners, and others who participate, e.g. facilitators and moderators. This disclosure pertains to relationships with pharmaceutical companies, biomedical device manufacturers or other corporations whose products or services are related to the subject matter of the presentation topic. Any real or apparent conflicts of interest related to the content of the presentations must be resolved prior to the educational activity. Disclosure of off-label, experimental or investigational drugs or devices must also be made known to the audience.